 | • レポートコード：QYR2104Z1076 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫学的・ワクチンアプローチ、抗増殖性アプローチ、光線力学療法、遺伝子治療アプローチ、細胞周期・アポトーシスアプローチ）、用途別市場規模（病院用、クリニック用、家庭用、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がん治療の市場動向 ・企業の競争状況、市場シェア ・がん治療の種類別市場規模（免疫学的・ワクチンアプローチ、抗増殖性アプローチ、光線力学療法、遺伝子治療アプローチ、細胞周期・アポトーシスアプローチ） ・がん治療の用途別市場規模（病院用、クリニック用、家庭用、その他） ・がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・がん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen、AstraZeneca、Bristol-Myers Squibb、Bayer AG、F. Hoffmann-La Roche Ltd、GlaxoSmithKline PLC、Johnson & Johnson、Merck & Co. Inc.、Novartis AG、Pfizer Inc.） ・結論 |
Cancer therapy describes the treatment of cancer in a patient, often with surgery, chemotherapy and/or radiotherapy. Targeted therapies are also available for some cancer types. A cancer patient might receive many different types of therapy, including those aimed at relieving the symptoms of cancer, such as pain.
North America dominates the global cancer therapy market, owing to high prevalence of cancer in the region because of a sedentary lifestyle, along with launch and growing adoption of novel cancer therapy in the region.
Market Analysis and Insights: Global Cancer Therapies Market
The global Cancer Therapies market size is projected to reach US$ 61690 million by 2026, from US$ 45240 million in 2019, at a CAGR of 4.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Therapies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Therapies market.
Global Cancer Therapies Scope and Market Size
Cancer Therapies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Immunological and Vaccine Approaches
Antiproliferative Approaches
Photodynamic Therapy
Gene Therapy Approaches
Cell Cycle and Apoptosis Approaches
Segment by Application
Hospital Use
Clinic Use
Household
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen
AstraZeneca
Bristol-Myers Squibb
Bayer AG
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis AG
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunological and Vaccine Approaches
1.2.3 Antiproliferative Approaches
1.2.4 Photodynamic Therapy
1.2.5 Gene Therapy Approaches
1.2.6 Cell Cycle and Apoptosis Approaches
1.3 Market by Application
1.3.1 Global Cancer Therapies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Therapies Market Perspective (2016-2027)
2.2 Cancer Therapies Growth Trends by Regions
2.2.1 Cancer Therapies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Therapies Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Therapies Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Therapies Industry Dynamic
2.3.1 Cancer Therapies Market Trends
2.3.2 Cancer Therapies Market Drivers
2.3.3 Cancer Therapies Market Challenges
2.3.4 Cancer Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Therapies Players by Revenue
3.1.1 Global Top Cancer Therapies Players by Revenue (2016-2021)
3.1.2 Global Cancer Therapies Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Therapies Revenue
3.4 Global Cancer Therapies Market Concentration Ratio
3.4.1 Global Cancer Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Therapies Revenue in 2020
3.5 Cancer Therapies Key Players Head office and Area Served
3.6 Key Players Cancer Therapies Product Solution and Service
3.7 Date of Enter into Cancer Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Therapies Breakdown Data by Type
4.1 Global Cancer Therapies Historic Market Size by Type (2016-2021)
4.2 Global Cancer Therapies Forecasted Market Size by Type (2022-2027)
5 Cancer Therapies Breakdown Data by Application
5.1 Global Cancer Therapies Historic Market Size by Application (2016-2021)
5.2 Global Cancer Therapies Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cancer Therapies Market Size (2016-2027)
6.2 North America Cancer Therapies Market Size by Type
6.2.1 North America Cancer Therapies Market Size by Type (2016-2021)
6.2.2 North America Cancer Therapies Market Size by Type (2022-2027)
6.2.3 North America Cancer Therapies Market Size by Type (2016-2027)
6.3 North America Cancer Therapies Market Size by Application
6.3.1 North America Cancer Therapies Market Size by Application (2016-2021)
6.3.2 North America Cancer Therapies Market Size by Application (2022-2027)
6.3.3 North America Cancer Therapies Market Size by Application (2016-2027)
6.4 North America Cancer Therapies Market Size by Country
6.4.1 North America Cancer Therapies Market Size by Country (2016-2021)
6.4.2 North America Cancer Therapies Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cancer Therapies Market Size (2016-2027)
7.2 Europe Cancer Therapies Market Size by Type
7.2.1 Europe Cancer Therapies Market Size by Type (2016-2021)
7.2.2 Europe Cancer Therapies Market Size by Type (2022-2027)
7.2.3 Europe Cancer Therapies Market Size by Type (2016-2027)
7.3 Europe Cancer Therapies Market Size by Application
7.3.1 Europe Cancer Therapies Market Size by Application (2016-2021)
7.3.2 Europe Cancer Therapies Market Size by Application (2022-2027)
7.3.3 Europe Cancer Therapies Market Size by Application (2016-2027)
7.4 Europe Cancer Therapies Market Size by Country
7.4.1 Europe Cancer Therapies Market Size by Country (2016-2021)
7.4.2 Europe Cancer Therapies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cancer Therapies Market Size (2016-2027)
8.2 Asia-Pacific Cancer Therapies Market Size by Type
8.2.1 Asia-Pacific Cancer Therapies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Therapies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Therapies Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Therapies Market Size by Application
8.3.1 Asia-Pacific Cancer Therapies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Therapies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Therapies Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Therapies Market Size by Region
8.4.1 Asia-Pacific Cancer Therapies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Therapies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Therapies Market Size (2016-2027)
9.2 Latin America Cancer Therapies Market Size by Type
9.2.1 Latin America Cancer Therapies Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Therapies Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Therapies Market Size by Type (2016-2027)
9.3 Latin America Cancer Therapies Market Size by Application
9.3.1 Latin America Cancer Therapies Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Therapies Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Therapies Market Size by Application (2016-2027)
9.4 Latin America Cancer Therapies Market Size by Country
9.4.1 Latin America Cancer Therapies Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Therapies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Therapies Market Size (2016-2027)
10.2 Middle East & Africa Cancer Therapies Market Size by Type
10.2.1 Middle East & Africa Cancer Therapies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Therapies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Therapies Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Therapies Market Size by Application
10.3.1 Middle East & Africa Cancer Therapies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Therapies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Therapies Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Therapies Market Size by Country
10.4.1 Middle East & Africa Cancer Therapies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Therapies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Cancer Therapies Introduction
11.1.4 Amgen Revenue in Cancer Therapies Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Cancer Therapies Introduction
11.2.4 AstraZeneca Revenue in Cancer Therapies Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Cancer Therapies Introduction
11.3.4 Bristol-Myers Squibb Revenue in Cancer Therapies Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Cancer Therapies Introduction
11.4.4 Bayer AG Revenue in Cancer Therapies Business (2016-2021)
11.4.5 Bayer AG Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Details
11.5.2 F. Hoffmann-La Roche Ltd Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Cancer Therapies Introduction
11.5.4 F. Hoffmann-La Roche Ltd Revenue in Cancer Therapies Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 GlaxoSmithKline PLC
11.6.1 GlaxoSmithKline PLC Company Details
11.6.2 GlaxoSmithKline PLC Business Overview
11.6.3 GlaxoSmithKline PLC Cancer Therapies Introduction
11.6.4 GlaxoSmithKline PLC Revenue in Cancer Therapies Business (2016-2021)
11.6.5 GlaxoSmithKline PLC Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Cancer Therapies Introduction
11.7.4 Johnson & Johnson Revenue in Cancer Therapies Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Merck & Co. Inc.
11.8.1 Merck & Co. Inc. Company Details
11.8.2 Merck & Co. Inc. Business Overview
11.8.3 Merck & Co. Inc. Cancer Therapies Introduction
11.8.4 Merck & Co. Inc. Revenue in Cancer Therapies Business (2016-2021)
11.8.5 Merck & Co. Inc. Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Cancer Therapies Introduction
11.9.4 Novartis AG Revenue in Cancer Therapies Business (2016-2021)
11.9.5 Novartis AG Recent Development
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Company Details
11.10.2 Pfizer Inc. Business Overview
11.10.3 Pfizer Inc. Cancer Therapies Introduction
11.10.4 Pfizer Inc. Revenue in Cancer Therapies Business (2016-2021)
11.10.5 Pfizer Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cancer Therapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunological and Vaccine Approaches
Table 3. Key Players of Antiproliferative Approaches
Table 4. Key Players of Photodynamic Therapy
Table 5. Key Players of Gene Therapy Approaches
Table 6. Key Players of Cell Cycle and Apoptosis Approaches
Table 7. Global Cancer Therapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cancer Therapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cancer Therapies Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Cancer Therapies Market Share by Regions (2016-2021)
Table 11. Global Cancer Therapies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Cancer Therapies Market Share by Regions (2022-2027)
Table 13. Cancer Therapies Market Trends
Table 14. Cancer Therapies Market Drivers
Table 15. Cancer Therapies Market Challenges
Table 16. Cancer Therapies Market Restraints
Table 17. Global Cancer Therapies Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Cancer Therapies Market Share by Players (2016-2021)
Table 19. Global Top Cancer Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Therapies as of 2020)
Table 20. Ranking of Global Top Cancer Therapies Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Cancer Therapies Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cancer Therapies Product Solution and Service
Table 24. Date of Enter into Cancer Therapies Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Cancer Therapies Revenue Market Share by Type (2016-2021)
Table 28. Global Cancer Therapies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Cancer Therapies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Cancer Therapies Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Cancer Therapies Revenue Market Share by Application (2016-2021)
Table 32. Global Cancer Therapies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Cancer Therapies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Cancer Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Cancer Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Cancer Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Cancer Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Cancer Therapies Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Cancer Therapies Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Cancer Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Cancer Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Cancer Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Cancer Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 64. Amgen Company Details
Table 65. Amgen Business Overview
Table 66. Amgen Cancer Therapies Product
Table 67. Amgen Revenue in Cancer Therapies Business (2016-2021) & (US$ Million)
Table 68. Amgen Recent Development
Table 69. AstraZeneca Company Details
Table 70. AstraZeneca Business Overview
Table 71. AstraZeneca Cancer Therapies Product
Table 72. AstraZeneca Revenue in Cancer Therapies Business (2016-2021) & (US$ Million)
Table 73. AstraZeneca Recent Development
Table 74. Bristol-Myers Squibb Company Details
Table 75. Bristol-Myers Squibb Business Overview
Table 76. Bristol-Myers Squibb Cancer Therapies Product
Table 77. Bristol-Myers Squibb Revenue in Cancer Therapies Business (2016-2021) & (US$ Million)
Table 78. Bristol-Myers Squibb Recent Development
Table 79. Bayer AG Company Details
Table 80. Bayer AG Business Overview
Table 81. Bayer AG Cancer Therapies Product
Table 82. Bayer AG Revenue in Cancer Therapies Business (2016-2021) & (US$ Million)
Table 83. Bayer AG Recent Development
Table 84. F. Hoffmann-La Roche Ltd Company Details
Table 85. F. Hoffmann-La Roche Ltd Business Overview
Table 86. F. Hoffmann-La Roche Ltd Cancer Therapies Product
Table 87. F. Hoffmann-La Roche Ltd Revenue in Cancer Therapies Business (2016-2021) & (US$ Million)
Table 88. F. Hoffmann-La Roche Ltd Recent Development
Table 89. GlaxoSmithKline PLC Company Details
Table 90. GlaxoSmithKline PLC Business Overview
Table 91. GlaxoSmithKline PLC Cancer Therapies Product
Table 92. GlaxoSmithKline PLC Revenue in Cancer Therapies Business (2016-2021) & (US$ Million)
Table 93. GlaxoSmithKline PLC Recent Development
Table 94. Johnson & Johnson Company Details
Table 95. Johnson & Johnson Business Overview
Table 96. Johnson & Johnson Cancer Therapies Product
Table 97. Johnson & Johnson Revenue in Cancer Therapies Business (2016-2021) & (US$ Million)
Table 98. Johnson & Johnson Recent Development
Table 99. Merck & Co. Inc. Company Details
Table 100. Merck & Co. Inc. Business Overview
Table 101. Merck & Co. Inc. Revenue in Cancer Therapies Business (2016-2021) & (US$ Million)
Table 102. Merck & Co. Inc. Recent Development
Table 103. Novartis AG Company Details
Table 104. Novartis AG Business Overview
Table 105. Novartis AG Cancer Therapies Product
Table 106. Novartis AG Revenue in Cancer Therapies Business (2016-2021) & (US$ Million)
Table 107. Novartis AG Recent Development
Table 108. Pfizer Inc. Company Details
Table 109. Pfizer Inc. Business Overview
Table 110. Pfizer Inc. Cancer Therapies Product
Table 111. Pfizer Inc. Revenue in Cancer Therapies Business (2016-2021) & (US$ Million)
Table 112. Pfizer Inc. Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Therapies Market Share by Type: 2020 VS 2027
Figure 2. Immunological and Vaccine Approaches Features
Figure 3. Antiproliferative Approaches Features
Figure 4. Photodynamic Therapy Features
Figure 5. Gene Therapy Approaches Features
Figure 6. Cell Cycle and Apoptosis Approaches Features
Figure 7. Global Cancer Therapies Market Share by Application: 2020 VS 2027
Figure 8. Hospital Use Case Studies
Figure 9. Clinic Use Case Studies
Figure 10. Household Case Studies
Figure 11. Other Case Studies
Figure 12. Cancer Therapies Report Years Considered
Figure 13. Global Cancer Therapies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Cancer Therapies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Cancer Therapies Market Share by Regions: 2020 VS 2027
Figure 16. Global Cancer Therapies Market Share by Regions (2022-2027)
Figure 17. Global Cancer Therapies Market Share by Players in 2020
Figure 18. Global Top Cancer Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Therapies as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Cancer Therapies Revenue in 2020
Figure 20. Global Cancer Therapies Revenue Market Share by Type (2016-2021)
Figure 21. Global Cancer Therapies Revenue Market Share by Type (2022-2027)
Figure 22. North America Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Cancer Therapies Market Share by Type (2016-2027)
Figure 24. North America Cancer Therapies Market Share by Application (2016-2027)
Figure 25. North America Cancer Therapies Market Share by Country (2016-2027)
Figure 26. United States Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Cancer Therapies Market Share by Type (2016-2027)
Figure 30. Europe Cancer Therapies Market Share by Application (2016-2027)
Figure 31. Europe Cancer Therapies Market Share by Country (2016-2027)
Figure 32. Germany Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Cancer Therapies Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Cancer Therapies Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Cancer Therapies Market Share by Region (2016-2027)
Figure 42. China Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Cancer Therapies Market Share by Type (2016-2027)
Figure 50. Latin America Cancer Therapies Market Share by Application (2016-2027)
Figure 51. Latin America Cancer Therapies Market Share by Country (2016-2027)
Figure 52. Mexico Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Cancer Therapies Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Cancer Therapies Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Cancer Therapies Market Share by Country (2016-2027)
Figure 58. Turkey Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Amgen Revenue Growth Rate in Cancer Therapies Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in Cancer Therapies Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Cancer Therapies Business (2016-2021)
Figure 64. Bayer AG Revenue Growth Rate in Cancer Therapies Business (2016-2021)
Figure 65. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cancer Therapies Business (2016-2021)
Figure 66. GlaxoSmithKline PLC Revenue Growth Rate in Cancer Therapies Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Cancer Therapies Business (2016-2021)
Figure 68. Merck & Co. Inc. Revenue Growth Rate in Cancer Therapies Business (2016-2021)
Figure 69. Novartis AG Revenue Growth Rate in Cancer Therapies Business (2016-2021)
Figure 70. Pfizer Inc. Revenue Growth Rate in Cancer Therapies Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の精密がん治療市場規模・現状・予測（2021年-2027年） Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy. Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormali…- 世界の卵巣がん遺伝子治療市場規模・現状・予測（2021年-2027年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- 世界のがん遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy refers to the introduction of foreign genes into target cells to correct or compensate for diseases caused by gene defects and/or abnormal gene expression. Market Analysis and Insights: Global Gene Therapy For Cancer Market The global Gene Therapy For Cancer market size is projected to …
- 世界のがん遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy refers to the introduction of foreign genes into target cells to correct or compensate for diseases caused by gene defects and/or abnormal gene expression. Market Analysis and Insights: Global Gene Therapy For Cancer Market The global Gene Therapy For Cancer market size is projected to …
- 世界のがん幹細胞（CSC）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …